What does the BIS options chain show right now?

As of May 15, 2026, ProShares - UltraShort Nasdaq Biotechnology (BIS) has 13 contracts outstanding and 0 traded today, with ATM IV of 50.0%. The full chain spans every listed strike and expiration with bid/ask, Greeks, volume, and open interest per contract.

What expirations are available for BIS options?

The nearest expiration is 34 days out, followed by 63 days. Listed expirations typically extend monthly with weeklies between, plus LEAPS one to two years out for liquid names.

How tight are BIS options bid/ask spreads?

Average bid/ask spread across the chain is 84.15%. Wider spreads warrant conservative sizing; mid-market fills are unreliable for retail-size orders.

ProShares - UltraShort Nasdaq Biotechnology (BIS) Options Chain

The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.

ProShares - UltraShort Nasdaq Biotechnology (BIS) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $2.4M, listed on NASDAQ, carrying a beta of -1.20 to the broader market. ProShares UltraShort Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index. public since 2010-04-09.

Snapshot as of May 15, 2026.

Spot Price: $8.76
Total OI: 13
Total Volume: 0
Front Expiration: 34 days
Second Expiration: 63 days
ATM IV: 50.0%
Avg Bid/Ask Spread: 84.15%

As of May 15, 2026, ProShares - UltraShort Nasdaq Biotechnology (BIS) has 13 open contracts and 0 contracts traded. The nearest expiration is 34 days out, followed by 63 days. ATM implied volatility is 50.0%. Average bid/ask spread across the chain is 84.15%: wider spreads, size positions conservatively. The options chain aggregates every listed strike and expiration, letting traders evaluate skew, term structure, and liquidity in a single view.

How BIS options chain Data Feeds Strategy Selection

Strategy selection on ProShares - UltraShort Nasdaq Biotechnology options does not derive from any single metric in isolation. The options chain view above sits inside a broader read: ATM IV currently sits at 50.0% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the options chain data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.

Learn how the options chain is reported and how to read the data →

Frequently asked BIS options chain questions

What does the BIS options chain show right now?: As of May 15, 2026, ProShares - UltraShort Nasdaq Biotechnology (BIS) has 13 contracts outstanding and 0 traded today, with ATM IV of 50.0%. The full chain spans every listed strike and expiration with bid/ask, Greeks, volume, and open interest per contract.
What expirations are available for BIS options?: The nearest expiration is 34 days out, followed by 63 days. Listed expirations typically extend monthly with weeklies between, plus LEAPS one to two years out for liquid names.
How tight are BIS options bid/ask spreads?: Average bid/ask spread across the chain is 84.15%. Wider spreads warrant conservative sizing; mid-market fills are unreliable for retail-size orders.